Dr Gerben Borst

Clinical Senior Lecturer

View graph of relations

Overview

Senior Lecturer at University of Manchester

Honorary Consultant Clinical Oncologist at Christie Hospital NHS Foundation Trust

Biography

Dr Gerben Borst obtained his MD at the University of Antwerp Medical School in Belgium and his PhD at the University of Amsterdam in The Netherlands. As part of his PhD, he was a resident at the Netherlands Cancer Institute (NKI) from 2003 – 2011 in the Department of Radiation Oncology. Gerben’s speciality training has taken him to Hokkaido University in Japan under the supervision of Professor Shirato (2007, UICC supported), the Institute of Cancer Research in London, under the supervision of Professor Kevin Harrington (2011, EACR and EMBO supported) and to Toronto working with Professor Rob Bristow at the Princess Margaret Cancer Centre (2015, KWF fellow). As a Consultant Radiation Oncologist, his clinical work at the NKI work included treating patients with primary brain tumours and patients with brain and spinal cord metastasis and he also did a the Ladislau and Melita Steiner Radiosurgery Fellowship at UCSF. He started to develop his own research group as an Assistant Professor at NKI investigating novel insights in the treatment response to develop innovative treatment strategies.

Gerben left the NKI in July 2020 and moved to the University of Manchester (UoM) as a Senior Lecturer and The Christie NHS Foundation Trust as an Honorary Consultant Clinical Oncologist. Gerben has a passion for developing the next generation of scientists and since 2018; he has supported PhD students as a primary supervisor at both NKI and UoM. His other passions include supporting colleagues with their research; he is a current member of the ‘Clinical and Translational Radiation Oncology’ Editorial Journal Board, a board member at the Geoffrey Jefferson Brain Research Centre, a reviewer of ESTRO abstracts and of multiple peer-reviewed journals (e.g. R&O, IJROBP and ctRO), in addition to teaching on the ESO-ESMO-ESTRO multidisciplinary course since 2016. At UoM and the Christie Hospital, Gerben continues his research into implementing better and innovative treatment strategies for patients with brain tumours.

Qualifications

Education

2003-2009                              PhD, Faculty of Medicine University of Amsterdam, Antoni van Leeuwenhoek Hospital, the Netherlands Cancer Institute, Amsterdam (co)supervisors: Prof. Harry Bartelink, Dr. Joos Lebesque, Prof. Jan-Jakob Sonke

1996-2003                              MD, Medical school, University Antwerp (UIA), Belgium

2000-2001                              Erasmus Exchange Program; Medical School Charité of University Medicine Berlin, Germany

Additional Qualifications

2012-2015                              Postdoctoral Fellowship, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada (Supervisor: Prof. Robert Bristow)

2010-2011                              Postdoctoral Fellowship, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom (Supervisor: Prof. Kevin Harrington)

2003-2011                              Resident, Radiation Oncology, Antoni van Leeuwenhoek Hospital, the Netherlands Cancer Institute, Amsterdam (Supervisors: Prof. Harry Bartelink, Prof. Marcel Verheij)

2007                                       Research Fellowship, Hokkaido University, Sapporo, Japan (Supervisor: Prof. H. Shirato)

Memberships of committees and professional bodies

- ESTRO

- ERRS

- NVRO

- AACR

- SNO

- EANO

Keywords

  • preclinical research, translational research, early phase clinical studies

Related information